Skip to main content
Premium Trial:

Request an Annual Quote

Tataa Biocenter to Distribute Strand's NGS Analysis Software in Europe

NEW YORK (GenomeWeb) – Tataa Biocenter and Strand Life Sciences have formed a strategic partnership, under which Tataa will distribute Strand's next-generation sequence data analysis software — Strand NGS — in Europe and also provide support for customers in that market.

Gӧteborg, Sweden-based Tataa also said that it will use Strand NGS, an integrated platform that offers tools for analyzing, managing, and visualizing NGS data, in its NGS training courses. Features of the platform include workflows for handling and analyzing DNA-seq, RNA-seq, small RNA-seq, ChIP-seq, and methyl-seq data; a browser tool for visualizing SNPs, insertions and deletions, large structural rearrangements, and more; and annotations for several standard organisms culled from various sources.

The partnership with Bangalore, India-based Strand enables Tataa to address customers' demands for comprehensive solutions that support their NGS workflows, Mikael Kubista, Tataa's president, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more